Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: An observational study.
Eleni Pitsouni, Themos Grigoriadis, Angeliki Tsiveleka...
https://pubmed.ncbi.nlm.nih.gov/27823733/Actively Recruiting
Led by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Updated on 2026-09-29
195
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to evaluate treatments for vulvo-vaginal atrophy in women with a history of breast cancer who cannot use hormonal therapies. It focuses on assessing the effectiveness and safety of a combined microfractionated C02 laser therapy and a non-hormonal topical regenerative treatment compared to each treatment alone. The study also examines the prevalence of genitourinary syndrome in these patients and its impact on their quality of life. Participants are randomly assigned to one of three groups a combination of laser treatment plus regenerative topical gel, regenerative topical gel alone, or laser treatment alone. The laser therapy involves three sessions spaced over several weeks, while the topical gel is applied twice daily for 36 months. The study follows a single-blind design where participants do not know their assigned treatment. Treatments are delivered through vaginal and vulvar applications using specialized devices and gels. During the study, participants will attend eight visits including treatment sessions and follow-ups over several months. Assessments include physical exams, gynecological ultrasounds, questionnaires on symptoms and quality of life, skin measurements, vaginal samples, and biopsies. Adverse events will be carefully monitored. Researchers will measure vulvo-vaginal symptoms and their intensity from baseline to six months after treatment. Safety, tolerability, and effects on urinary symptoms are also evaluated throughout the study.
CONDITIONS
A Laser and Topical Treatment Combination in the Vulvo-vaginal Atrophy Management in Breast Cancer Patients.
A
Amalia Cañadas Molina
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Lead Sponsor
Lumenis Be Ltd.
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit before treatment
Duration - Approximately 3 months
Participants receive their assigned treatments including laser sessions and/or topical gel application as per study group.
6 treatment and review visits over 3 months
Duration - 6 months
Participants are monitored with clinical assessments and questionnaires to evaluate symptom changes and safety for six months after treatment ends.
2 follow-up visits after treatment completion
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Eleni Pitsouni, Themos Grigoriadis, Angeliki Tsiveleka...
https://pubmed.ncbi.nlm.nih.gov/27823733/Carolyn Crandall, Laura Petersen, Patricia A Ganz...
https://pubmed.ncbi.nlm.nih.gov/15356404/Eleni Pitsouni, Themos Grigoriadis, Matthew E Falagas...
https://pubmed.ncbi.nlm.nih.gov/28778337/Stefania Alvisi, Maurizio Baldassarre, Valentina Martelli...
https://pubmed.ncbi.nlm.nih.gov/28562130/José López-López, Enric Jané Salas, Eduardo Chimenos Küstner
https://pubmed.ncbi.nlm.nih.gov/23726507/Dudley Robinson, Richard Flint, Nikolaus Veit-Rubin...
https://pubmed.ncbi.nlm.nih.gov/32040871/H Välimaa, S Savolainen, T Soukka...
https://pubmed.ncbi.nlm.nih.gov/14709144/Rossella E Nappi, Santiago Palacios, Martire Particco...
https://pubmed.ncbi.nlm.nih.gov/27451325/Swati Jha, Lynda Wyld, Priyanka H Krishnaswamy
https://pubmed.ncbi.nlm.nih.gov/31227415/Mateya Trinkaus, Sheray Chin, Wendy Wolfman...
https://pubmed.ncbi.nlm.nih.gov/18378532/Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Lead Sponsor
Lumenis Be Ltd.
Collaborating Sponsor